FDA Approved: DAYBUE — Original Application (Acadia Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved DAYBUE (trofinetide) from Acadia Pharmaceuticals as the first approved treatment for Rett syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• DAYBUE (trofinetide)

Snippet

ORIG AP for DAYBUE (TROFINETIDE)